Skip to main content
OpenTrials
Completed

NCT Number: NCT06452810

A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area

This virtual single-group clinical trial aims to evaluate the effects of the Sahajan Golden Glow Balm on the health and appearance of the skin in the periorbital area over a period of 6 weeks. Participants will apply the product twice daily and complete questionnaires at various intervals. Photos for expert skin grading will be taken at Baseline and Week 6.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Skin Health

Age range

35 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Santa Monica, California, 90404, United States

About this study

The study will investigate the impact of Sahajan Golden Glow Balm on skin health, particularly focusing on fine lines, wrinkles, dark circles, and dry eyes. It involves 35 female participants aged 35 and above, who will use the product for 6 weeks and complete periodic questionnaires and provide photos for dermatological assessment.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Concerns with the appearance of skin in the periorbital area
  • Willing to maintain the same skincare routine for the study duration
  • Must own a smartphone or digital camera for photos

Exclusion criteria

  • Medical conditions affecting skin health
  • Use of medications or products that could affect skin health
  • Pregnancy or breastfeeding
  • Participation in another clinical study

Treatment and study plan

Experimental: Sahajan Golden Glow Balm

Dietary Supplement

Participants will apply the Sahajan Golden Glow Balm twice daily (morning and night) to the periorbital area following the specified instructions.

Primary outcomes

  1. Changes in the Health and Appearance of the Skin in the Periorbital Area

    Time frame: Baseline to Week 6

    The primary outcome measure will assess changes in the health and appearance of the skin in the periorbital area, evaluated via expert skin grading by a board-certified dermatologist.

Secondary outcomes

  1. Changes in Participants' Perception of the Appearance of the Skin in the Periorbital Area

    Time frame: Baseline, Day 1, Week 2, Week 4, and Week 6

    The secondary outcome measure will evaluate changes in participants' perception of the appearance of their skin in the periorbital area, including the appearance of fine lines, wrinkles, dark circles, and dry skin, using participant-reported questionnaires.

Sponsors and collaborators

Lead sponsor

Sahajan

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jun 11, 2024
Registry last updated
Jun 11, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.